dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Bravo Garmendia, Miren |
dc.contributor.author | Raurell Saborit, Immaculada |
dc.contributor.author | Barbera Belles, Aurora |
dc.contributor.author | Hide Alferez, Diana |
dc.contributor.author | Estrella Gonzalez, Federico |
dc.contributor.author | Salcedo Allende, Maria Teresa |
dc.contributor.author | Genescà Ferrer, Joan |
dc.contributor.author | Gil Soler, Mar |
dc.contributor.author | Martell Pérez-Alcalde, Maria |
dc.contributor.author | Augustin Recio, Salvador |
dc.date.accessioned | 2022-01-12T11:41:52Z |
dc.date.available | 2022-01-12T11:41:52Z |
dc.date.issued | 2021-05 |
dc.identifier.citation | Bravo M, Raurell I, Barberá A, Hide D, Gil M, Estrella F, et al. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH. Dis Model Mech. 2021 May;14(5):dmm048884. |
dc.identifier.issn | 1754-8403 |
dc.identifier.uri | https://hdl.handle.net/11351/6765 |
dc.description | Ambrisentan; Endotelina-1; Cèl·lules estelades hepàtiques |
dc.description.sponsorship | This work was supported by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (European Regional Development Fund/European Social Fund, ‘Investing in your future’) [PI17/00310 to S.A., PI17/00754 to M.M., and PI18/00947 and AC18/00033 (ENM3 2018) to J.G.]. J.G. is a recipient of a clinical intensification award and D.H. is a recipient of a Sara Borrell grant (both from ISCIII). M.G. and A.B. have predoctoral fellowships from the Agència de Gestió d'Ajuts Universitaris i de Recerca and ISCIII, respectively. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) is supported by ISCIII. |
dc.language.iso | eng |
dc.publisher | Company Biologists |
dc.relation.ispartofseries | Disease Models & Mechanisms;14(5) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Fetge - Malalties - Tractament |
dc.subject | Rates |
dc.subject.mesh | Liver Diseases |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Rats |
dc.title | Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1242/dmm.048884 |
dc.subject.decs | enfermedades hepáticas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | ratas |
dc.relation.publishversion | https://doi.org/10.1242/dmm.048884 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Bravo M, Barberá A, Gil M, Estrella F] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Raurell I, Hide D, Augustin S, Genescà J, Martell M] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid 28029, Spain. [Salcedo MT] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 34014280 |
dc.identifier.wos | 000663756700006 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00947 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI17%2F00754 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/AC18%2F00033 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |